In practice, most studies, including ours, indicate that triplicate core assessment using a 0.6 mm core size is sufficient for the accurate evaluation of Ki67 and also MCM2 in invasive breast cancer tissue [33, 34]. Here, MKI67 is linked to invasive breast carcinoma.